Mirae Asset Global Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Mirae Asset Global Investments’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,838	Closed	-$1.31M	–	2662
2023 Q2	$1.31M	Sell	12,838 -45	-0.3%	-$4.26K	﹤0.01%	1418
2023 Q1	$1.17M	Buy	12,883 +184	+1%	+$10.8K	﹤0.01%	1459
2022 Q4	$482K	Buy	12,699 +15	+0.1%	+$516	﹤0.01%	1915
2022 Q3	$319K	Buy	+12,684	New	+$352K	﹤0.01%	2135

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global Investments's RETA Position: Q3 2023 in Review

Mirae Asset Global Investments sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 12,838 shares — an estimated $1.31M sold.

Mirae Asset Global Investments first reported a position in RETA in Q3 2022 and held it in 4 quarters. The position peaked at $1.31M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Mirae Asset Global Investments reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Mirae Asset Global Investments sold 12,838 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.31M.
Mirae Asset Global Investments first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2022 and held it in 4 quarters.
Mirae Asset Global Investments's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.31M in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Mirae Asset Global Investments's 13F filing for Q3 2023, filed 26 Oct 2023.